Lymphadenopathy surgery: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(13 intermediate revisions by 3 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Lymphadenopathy}}
{{Lymphadenopathy}}
{{CMG}}; {{AE}}{{ADS}},{{RT}}
{{CMG}}; {{AE}}{{ADS}},{{RT}}{{DYM}}


==Overview==
==Overview==
Surgery is not the first-line treatment option for patients with lymphadenopathy. Surgery is usually reserved for patients with either malignancy and an indication of biopsy. It involves removal or aspiration of lymph nodes. They are dissected when the cancer is in an advanced stage.
Surgery is not the first-line treatment option for patients with [[lymphadenopathy]]. Surgery is usually reserved for patients with either malignancy and an indication of [[biopsy]]. It involves the removal or aspiration of [[lymph nodes]]. They are dissected when [[cancer]] is in an advanced stage.


==Indications==
==Indications==
*Surgery is not the first-line treatment option for patients with lymphadenopathy. It depends upon the underlying diagnosis. Surgery is usually reserved for patients with either:<ref name="pmid300206222">{{cite journal |vauthors=Freeman AM, Matto P |title= |journal= |volume= |issue= |pages= |date= |pmid=30020622 |doi= |url=}}</ref>
 
**malignancy
*[[Surgery]] is not the first-line treatment option for patients with lymphadenopathy. It depends upon the underlying diagnosis. [[Surgery]] is usually reserved for patients with either:<ref name="pmid300206222">{{cite journal |vauthors=Freeman AM, Matto P |title= Adenopathy|date= December 13, 2018 |pmid=30020622 |url=https://www.ncbi.nlm.nih.gov/books/NBK513250/#article-40409.s7}}</ref>
**biopsy required for staging
**[[Malignancy]]
**[[Biopsy]] required for staging<ref name="pmid30430795">{{cite journal |vauthors=Dorfman T, Neymark M, Begal J, Kluger Y |title=Surgical Biopsy of Pathologically Enlarged Lymph Nodes: A Reappraisal |journal=Isr Med Assoc J |volume=20 |issue=11 |pages=674–678 |date=November 2018 |pmid=30430795 |doi= |url=}}</ref>
 
==Surgery==
==Surgery==
*The feasibility of surgery depends on the underlying diagnosis.
A surgical [[biopsy]] also has its role in the clinical evaluation of patients with enlarged [[lymph nodes]]. [[Surgery]], particularly in patients with suspected [[lymphoma]] recurrence, can significantly reduce the duration of the investigation and avoid unnecessary diagnosis.<ref name="pmid30430795">{{cite journal |vauthors=Dorfman T, Neymark M, Begal J, Kluger Y |title=Surgical Biopsy of Pathologically Enlarged Lymph Nodes: A Reappraisal |journal=Isr Med Assoc J |volume=20 |issue=11 |pages=674–678 |date=November 2018 |pmid=30430795 |doi= |url=}}</ref>
* Surgical care involves open [[biopsy]] or aspiration of the lymph node and its removal.
 
* Lymph nodes are dissected when the cancer is in an advanced stage.<ref name="pmid30020622">{{cite journal |vauthors=Freeman AM, Matto P |title= |journal= |volume= |issue= |pages= |date= |pmid=30020622 |doi= |url=}}</ref>
*The feasibility of [[surgery]] depends on the underlying diagnosis.
*Surgical care involves open [[biopsy]] or aspiration of the lymph node and its removal.
*Lymph nodes are dissected when the cancer is in an advanced stage.
 
==References==
==References==
{{reflist|2}}
{{reflist|2}}
{{WH}}
{{WS}}


[[Category:primary care]]
[[Category:Inflammations]]
[[Category:Inflammations]]
[[Category:Dermatology]]
[[Category:Dermatology]]
[[Category:Hematology]]
[[Category:Hematology]]
[[Category:Physical examination]]
[[Category:Physical examination]]
{{WH}}
{{WS}}

Latest revision as of 15:36, 26 April 2021

Lymphadenopathy Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Lymphadenopathy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT scan

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Lymphadenopathy surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Lymphadenopathy surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Lymphadenopathy surgery

CDC on Lymphadenopathy surgery

Lymphadenopathy surgery in the news

Blogs on Lymphadenopathy surgery

Directions to Hospitals Treating Lymphadenopathy

Risk calculators and risk factors for Lymphadenopathy surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2],Raviteja Guddeti, M.B.B.S. [3]Delband Yekta Moazami, M.D.[4]

Overview

Surgery is not the first-line treatment option for patients with lymphadenopathy. Surgery is usually reserved for patients with either malignancy and an indication of biopsy. It involves the removal or aspiration of lymph nodes. They are dissected when cancer is in an advanced stage.

Indications

  • Surgery is not the first-line treatment option for patients with lymphadenopathy. It depends upon the underlying diagnosis. Surgery is usually reserved for patients with either:[1]

Surgery

A surgical biopsy also has its role in the clinical evaluation of patients with enlarged lymph nodes. Surgery, particularly in patients with suspected lymphoma recurrence, can significantly reduce the duration of the investigation and avoid unnecessary diagnosis.[2]

  • The feasibility of surgery depends on the underlying diagnosis.
  • Surgical care involves open biopsy or aspiration of the lymph node and its removal.
  • Lymph nodes are dissected when the cancer is in an advanced stage.

References

  1. Freeman AM, Matto P (December 13, 2018). "Adenopathy". PMID 30020622.
  2. 2.0 2.1 Dorfman T, Neymark M, Begal J, Kluger Y (November 2018). "Surgical Biopsy of Pathologically Enlarged Lymph Nodes: A Reappraisal". Isr Med Assoc J. 20 (11): 674–678. PMID 30430795.

Template:WH Template:WS